SIRT1 mediates hypoxic postconditioning- and resveratrol-induced protection against functional connectivity deficits after subarachnoid hemorrhage.
Julian V ClarkeLindsey M BrierRachel M RahnDeepti DiwanJane Y YuanAnnie R BiceShin-Ichiro ImaiAnanth K VellimanaJoseph P CulverGregory J ZipfelPublished in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2022)
Functional connectivity (FC) is a sensitive metric that provides a readout of whole cortex coordinate neural activity in a mouse model. We examine the impact of experimental SAH modeled through endovascular perforation, and the effectiveness of subsequent treatment on FC, through three key questions: 1) Does the endovascular perforation model of SAH induce deficits in FC; 2) Does exposure to hypoxic conditioning provide protection against these FC deficits and, if so, is this neurovascular protection SIRT1-mediated; and 3) does treatment with the SIRT1 activator resveratrol alone provide protection against these FC deficits? Cranial windows were adhered on skull-intact mice that were then subjected to either sham or SAH surgery and either left untreated or treated with hypoxic post-conditioning (with or without EX527) or resveratrol for 3 days. Mice were imaged 3 days post-SAH/sham surgery, temporally aligned with the onset of major SAH sequela in mice. Here we show that the endovascular perforation model of SAH induces global and network-specific deficits in FC by day 3, corresponding with the time frame of DCI in mice. Hypoxic conditioning provides SIRT1-mediated protection against these network-specific FC deficits post-SAH, as does treatment with resveratrol. Conditioning-based strategies provide multifaceted neurovascular protection in experimental SAH.
Keyphrases
- functional connectivity
- resting state
- traumatic brain injury
- subarachnoid hemorrhage
- oxidative stress
- ischemia reperfusion injury
- mouse model
- high fat diet induced
- minimally invasive
- systematic review
- randomized controlled trial
- cerebral ischemia
- combination therapy
- coronary artery disease
- skeletal muscle
- adipose tissue
- blood brain barrier
- endothelial cells
- wild type
- newly diagnosed